We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.83%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
+$2.18B
(+5%)
Cap. Flow
+$425M
Cap. Flow
% of AUM
0.92%
Top 10 Holdings %
Top 10 Hldgs %
15.17%
Holding
2,954
New
28
Increased
2,252
Reduced
604
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$128M |
| 2 |
Baker Hughes
BKR
|
+$26.7M |
| 3 |
IQVIA
IQV
|
+$14.5M |
| 4 |
Oneok
OKE
|
+$14.3M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$11.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$114M |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$88.6M |
| 3 |
BHI
Baker Hughes
BHI
|
+$41.6M |
| 4 |
WFM
Whole Foods Market Inc
WFM
|
+$26.7M |
| 5 |
UnitedHealth
UNH
|
+$22.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.64% |
| 2 | Technology | 15.8% |
| 3 | Healthcare | 13.57% |
| 4 | Industrials | 10.87% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCF
1951
DELISTED
Chase Corporation
CCF
| $1.04M | ﹤0.01% |
9,346
+139
| +2% | +$14.1K |
|
|
ARNA
1952
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.04M | ﹤0.01% |
40,771
+4,657
| +13% | +$107K |
|
|
ECHO
1953
DELISTED
Echo Global Logistics, Inc.
ECHO
| $1.04M | ﹤0.01% |
54,960
+840
| +2% | +$13.8K |
|
|
PTHN
1954
DELISTED
Patheon N.V.
PTHN
| $1.03M | ﹤0.01% |
29,599
-6,128
| -17% | -$214K |
|
1955
Titan International
TWI
$466M
| $1.03M | ﹤0.01% |
101,844
+2,640
| +3% | +$27.5K |
|
1956
Camping World
CWH
$639M
| $1.03M | ﹤0.01% |
25,326
+10,883
| +75% | +$377K |
|
1957
United Parks & Resorts
PRKS
$2.1B
| $1.03M | ﹤0.01% |
79,212
+1,005
| +1% | +$13.8K |
|
|
ESPR
1958
DELISTED
Esperion Therapeutics
ESPR
| $1.03M | ﹤0.01% |
20,500
+1,960
| +11% | +$94.5K |
|
1959
Omeros
OMER
$857M
| $1.02M | ﹤0.01% |
47,412
+780
| +2% | +$16.5K |
|
|
BFX
1960
DELISTED
BowFlex Inc.
BFX
| $1.02M | ﹤0.01% |
60,636
+1,205
| +2% | +$20.8K |
|
1961
Comtech Telecommunications
CMTL
$50.3M
| $1.02M | ﹤0.01% |
49,823
+2,331
| +5% | +$44.7K |
|
1962
Myers Industries
MYE
$1.29B
| $1.02M | ﹤0.01% |
48,785
+1,039
| +2% | +$19.1K |
|
|
PGNX
1963
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $1.02M | ﹤0.01% |
138,707
+2,970
| +2% | +$18.9K |
|
|
CCRN
1964
DELISTED
Cross Country Healthcare
CCRN
| $1.02M | ﹤0.01% |
71,605
+4,242
| +6% | +$53.1K |
|
|
DEA
1965
Easterly Government Properties
DEA
$1.13B
| $1.02M | ﹤0.01% |
19,711
-91
| -0.5% | -$4.57K |
|
|
EGRX
1966
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.02M | ﹤0.01% |
17,076
+1,080
| +7% | +$65.3K |
|
|
XOXO
1967
DELISTED
Xo Group Inc
XOXO
| $1.02M | ﹤0.01% |
51,768
+665
| +1% | +$12.2K |
|
1968
Atlanta Braves Holdings Series B
BATRK
$3.26B
| $1.01M | ﹤0.01% |
40,078
-208
| -0.5% | -$5.13K |
|
|
AAMI
1969
Acadian Asset Management
AAMI
$3.08B
| $1.01M | ﹤0.01% |
67,762
+9,750
| +17% | +$139K |
|
1970
TriCo Bancshares
TCBK
$1.84B
| $1.01M | ﹤0.01% |
24,787
+130
| +0.5% | +$4.69K |
|
1971
AMC Entertainment Holdings
AMC
$2.52B
| $1.01M | ﹤0.01% |
6,855
+37
| +0.5% | +$6.18K |
|
1972
Columbus McKinnon
CMCO
$553M
| $1.01M | ﹤0.01% |
26,553
+950
| +4% | +$29K |
|
1973
Houlihan Lokey
HLI
$8.77B
| $1M | ﹤0.01% |
25,660
+551
| +2% | +$20.1K |
|
1974
MarineMax
HZO
$759M
| $1M | ﹤0.01% |
60,668
+643
| +1% | +$10.5K |
|
|
FINL
1975
DELISTED
Finish Line
FINL
| $1M | ﹤0.01% |
83,341
+2,452
| +3% | +$29.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2017 Portfolio in Review
As of Q3 2017, RhumbLine Advisers held 2,954 positions worth $46B, up 5% from $43.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q3 2017: portfolio turnover was 2.6%. RhumbLine Advisers opened 28 new positions and exited 50, leaving the 2,954-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q3 2017 buy was Baker Hughes: 750,985 shares worth $27.5M.
- RhumbLine Advisers added most to DuPont de Nemours in Q3 2017, an estimated $128M increase.
- RhumbLine Advisers's biggest Q3 2017 reduction was UnitedHealth, cutting an estimated $22.8M.
- RhumbLine Advisers fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $114M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $46B portfolio in Q3 2017.
- RhumbLine Advisers opened 28 new positions and closed 50 in Q3 2017.
- RhumbLine Advisers's portfolio value rose 5% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q3 2017, filed 6 Nov 2017.